Efficacy of donepezil treatment in Alzheimer patients with and without subcortical vascular lesions

Pharmacology

Volumn 72, Issue 1, 2004, Pages 1-5

  Blasko, Imrich ^a   Bodner, Thomas ^a   Knaus, Gabriele ^a   Walch, Thomas ^a   Monsch, Andreas ^b   Hinterhuber, Hartmann ^a   Marksteiner, Josef ^a,c  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Alzheimer's disease; Cerebrovascular disease; Donepezil; Mixed dementia

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; DONEPEZIL; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; VITAMIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TREATMENT OUTCOME; VASCULAR LESION;

AGED; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; COMORBIDITY; DEMENTIA, VASCULAR; FEMALE; HUMANS; INDANS; MALE; MIDDLE AGED; NOOTROPIC AGENTS; PIPERIDINES; REGISTRIES; TREATMENT OUTCOME;

EID: 4043164842     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078625     Document Type: Article

References (18)

1. Kalaria RN, Ballard C: Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 1999;13(suppl 3):S115-S123.
2. Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV: Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: A randomised trial. Lancet 2002;359:1283-1290.
3. Meyer JS, Chowdhury MH, Xu G, Li YS, Quach M: Donepezil treatment of vascular dementia. Ann NY Acad Sci 2002;977:482-486.
4. Pratt RD, Perdomo CA: Donepezil-treated patients with probable vascular dementia demonstrate cognitive benefits. Ann NY Acad Sci 2002;977:513-522.
5. Black S, Roman GC, Geldmacher DS, Salloway S, Hecker J, Burns A, Perdomo C, Kumar D, Pratt R: Efficacy and tolerability of donepezil in vascular dementia: Positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke 2003;34:2323-2330.
6. Wilkinson D, Doody R, Helme R, Taubman K, Mintzer J, Kertesz A, Pratt RD: Donepezil in vascular dementia: A randomized, placebo-controlled study. Neurology 2003;61:479-486.
7. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997;277:925-926.
8. Davis PB, Morris JC, Grant E: Brief screening tests versus clinical staging in senile dementia of the Alzheimer type. J Am Geriatr Soc 1990;38:129-135.
9. Welsh K, Butters N, Hughes J, Mohs R, Heyman A: Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol 1991;48:278-281.
10. Welsh KA, Butters N, Hughes JP, Mohs RC, Heyman A: Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol 1992;49:448-452.
11. Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fillenbaum G, Heyman A: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology 1994;44:609-614.
12. Monsch AU: Neuropsychological examination in evaluating dementia (in German). Schweiz Rundsch Med Prax 1997;86:1340-1342.
13. Berres M, Monsch AU, Bernasconi F, Thalmann B, Stahelin HB: Normal ranges of neuropsychological tests for the diagnosis of Alzheimer's disease. Stud Health Technol Inform 2000;77:195-199.
14. Folstein MF, Robins LN, Helzer JE: The Mini-Mental State Examination. Arch Gen Psychiatry 1983;40:812.
15. Scarpini E, Scheltens P, Feldman H: Treatment of Alzheimer's disease: Current status and new perspectives. Lancet Neurol 2003;2:539-547.
16. Schmidtke K, Hull M: Neuropsychological differentiation of small vessel disease, Alzheimer's disease and mixed dementia. J Neurol Sci 2002;203-204:17-22.
17. Tierney MC, Black SE, Szalai JP, Snow WG, Fisher RH, Nadon G, Chui HC: Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia. Arch Neurol 2001;58:1654-1659.
18. Frolich L: The cholinergic pathology in Alzheimer's disease - Discrepancies between clinical experience and pathophysiological findings. J Neural Transm 2002;109:1003-1013.